Last update 24 May 2025

Triamcinolone/Moxifloxacin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
Bacterial DNA gyrase x Bacterial top IV x GR
Action
inhibitors, agonists
Mechanism
Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors), GR agonists(Glucocorticoid receptor agonists)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic DiseaseEye Diseases
Active Indication-
Inactive Indication
Diabetic macular oedema
Originator Organization
Loma Linda UniversityLoma Linda University
Active Organization-
Inactive Organization
Loma Linda UniversityLoma Linda University
License Organization-
Drug Highest PhasePendingClinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Triamcinolone/Moxifloxacin
Login to view more data
100 Translational Medicine associated with Triamcinolone/Moxifloxacin
Login to view more data
100 Patents (Medical) associated with Triamcinolone/Moxifloxacin
Login to view more data
100 Deals associated with Triamcinolone/Moxifloxacin
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic macular oedemaClinical
United States
Loma Linda UniversityLoma Linda University
01 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ARVO2021
Not Applicable
Ophthalmologic surgical procedures
401
Intravitreal Triamcinolone Acetonide-Moxifloxacin
pjwzimssfm(giluavsptr) = cbaaydlvoa ymzufjalec (rrowkourfn )
-
01 Jun 2021
Intracameral Dexamethasone-Moxifloxacin-Ketorolac
pjwzimssfm(giluavsptr) = zbmybpwfog ymzufjalec (rrowkourfn )
2020 ARVO Annual Meeting (ARVO2020)
Not Applicable
Inflammation | Infectious Diseases
198
Intraoperative Triamcinolone-Moxifloxacin Injection
juaaeluefr(dorvgmrewb) = gknthqkrih lfitttrfwi (ekorlfwpsn )
Positive
01 Jun 2020
Postoperative Polymyxin B/Trimethoprim and Prednisolone Acetate 1% Eye Drops
juaaeluefr(dorvgmrewb) = ekmqhqgkmv lfitttrfwi (ekorlfwpsn )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free